Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Robak

Showing results (91-100 of 292) with videos related to

Pageof 30
Sort By:
Postepy Higieny I Medycyny Doswiadczalnej|January 1, 1997
[Cytokines in rheumatoid arthritis]T Robak, A Gladalska
Archivum Immunologiae Et Therapiae Experimentalis|June 5, 1998
Interactions of 2',2'-diflurodeoxycytidine (gemcitabine) with tumor necrosis factor alpha or its mutein VI in murine leukemias L1210 and P388E Marańda, T Robak
Postepy Higieny I Medycyny Doswiadczalnej|May 1, 1978
[Experimental methods used in the evaluation of antitumor action of new agents]J Graczyk, T Robak
Leukemia Research|December 11, 1997
The influence of recombinant human tumor necrosis factor alpha and its muteins used alone or in combination with 2-chlorodeoxyadenosine on normal and leukemic hematopoiesis in vitroA Korycka, T Robak
Postepy Higieny I Medycyny Doswiadczalnej|December 19, 1998
[Biological properties and clinical significance of interleukins 12 (IL-12)]E Marańda, T Robak
Polskie Archiwum Medycyny Wewnetrznej|October 7, 1998
[Cytokines in multiple myeloma]A Wierzbowska, T Robak
Acta Haematologica Polonica|January 1, 1992
[2-chlorodeoxyadenosine (2-CDA)--a new antineoplastic and immunosuppressive drug]T Robak, P Grieb
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|May 21, 1990
[Clinical pharmacology of bleomycin]J Drzewoski, T Robak
Leukemia|June 1, 2002
Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemiaT Robak, M Kasznicki
Polskie Archiwum Medycyny Wewnetrznej|November 5, 2002
[Treatment of acute myelogenous leukemia in elderly patients]A Wierzbowska, T Robak
Pageof 30

Showing results (91-100 of 292) with videos related to

Sort By:
Pageof 30
Postepy Higieny I Medycyny Doswiadczalnej|January 1, 1997
[Cytokines in rheumatoid arthritis]T Robak, A Gladalska
Archivum Immunologiae Et Therapiae Experimentalis|June 5, 1998
Interactions of 2',2'-diflurodeoxycytidine (gemcitabine) with tumor necrosis factor alpha or its mutein VI in murine leukemias L1210 and P388E Marańda, T Robak
Postepy Higieny I Medycyny Doswiadczalnej|May 1, 1978
[Experimental methods used in the evaluation of antitumor action of new agents]J Graczyk, T Robak
Leukemia Research|December 11, 1997
The influence of recombinant human tumor necrosis factor alpha and its muteins used alone or in combination with 2-chlorodeoxyadenosine on normal and leukemic hematopoiesis in vitroA Korycka, T Robak
Postepy Higieny I Medycyny Doswiadczalnej|December 19, 1998
[Biological properties and clinical significance of interleukins 12 (IL-12)]E Marańda, T Robak
Polskie Archiwum Medycyny Wewnetrznej|October 7, 1998
[Cytokines in multiple myeloma]A Wierzbowska, T Robak
Acta Haematologica Polonica|January 1, 1992
[2-chlorodeoxyadenosine (2-CDA)--a new antineoplastic and immunosuppressive drug]T Robak, P Grieb
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|May 21, 1990
[Clinical pharmacology of bleomycin]J Drzewoski, T Robak
Leukemia|June 1, 2002
Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemiaT Robak, M Kasznicki
Polskie Archiwum Medycyny Wewnetrznej|November 5, 2002
[Treatment of acute myelogenous leukemia in elderly patients]A Wierzbowska, T Robak
Pageof 30